Interim monitoring plans to simultaneously evaluate a composite end point and a severe adverse event that is part of the composite end point (vol 22,pg S32, 2001)

Authors
Thompson, BW Knatterud, GL
Citation
Bw. Thompson et Gl. Knatterud, Interim monitoring plans to simultaneously evaluate a composite end point and a severe adverse event that is part of the composite end point (vol 22,pg S32, 2001), CONTR CL TR, 22(3), 2001, pp. 355-355
Citations number
1
Categorie Soggetti
Pharmacology,"Medical Research General Topics
Journal title
CONTROLLED CLINICAL TRIALS
ISSN journal
01972456 → ACNP
Volume
22
Issue
3
Year of publication
2001
Pages
355 - 355
Database
ISI
SICI code
0197-2456(200106)22:3<355:IMPTSE>2.0.ZU;2-B